A Randomized, Controlled Safety, and Immunogenicity Trial of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults

Human immunodeficiency virus (HIV)-associated tuberculosis is a major public health threat. We evaluated the safety and immunogenicity of the candidate tuberculosis vaccine M72/AS01 in HIV-positive and HIV-negative Indian adults. Randomized, controlled observer-blind trial (NCT01262976). We assigned...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumarasamy, Nagalingeswaran, Poongulali, Selvamuthu, Bollaerts, Anne, Moris, Philippe, Beulah, Faith Esther, Ayuk, Leo Njock, Demoitié, Marie-Ange, Jongert, Erik, Ofori-Anyinam, Opokua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4850
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998253/
https://www.ncbi.nlm.nih.gov/pubmed/26817879
http://dx.doi.org/10.1097/MD.0000000000002459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998253/
https://www.ncbi.nlm.nih.gov/pubmed/26817879
http://dx.doi.org/10.1097/MD.0000000000002459

Ejemplares similares